Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering,developing and commercializing a cure for people with chronic hepatitis B virus ("HBV") infection. They are advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery…More and development effort for treating coronaviruses (including COVID-19).